Krystal JH
Department of Psychiatry, Yale University School of Medicine; New Haven, CT, USA.
ArticleKetamine
Ketamine Alters Tuning of Neural and Behavioral Spatial Working Memory Precision.
ArticlePsilocybin
α<sub>2</sub>-Adrenergic receptor modulates 5-HT<sub>2A</sub>-mediated behavioral effects of MDMA and psilocybin in mice.
ArticleKetamine
Ketamine Infusions and Rapid Reduction of Suicidal and Depressive Symptoms in Major Depressive Episode: A Systematic Review and Meta-Analysis.
PreprintPsilocybin
Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response
PreprintMDMA
MDMA enhances prefrontal plasticity and representational drift during fear extinction
ArticleKetamine
Combining DNA methylation features and clinical characteristics predicts ketamine treatment response for PTSD.
ArticleKetamine
Ketamine for Depression, but at What Cost? A Review of Ketamine's Neurotoxic Effects From Preclinical and Human Studies.
ArticlePsilocybin
Psilocybin: From Psychiatric Pariah to Perceived Panacea.
ArticleMDMA
MDMA and MDMA-Assisted Therapy.
ArticleKetamine
Ketamine induces multiple individually distinct whole-brain functional connectivity signatures.
ArticleKetamine
Recent Advances in the Treatment of Treatment-Resistant Depression: A Narrative Review of Literature Published from 2018 to 2023.
ArticleKetamine
Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments.
ArticleKetamine
Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms.
ArticleKetamine
Characteristics of Esketamine Prescribers Among Medicare Beneficiaries in the United States, 2019-2020.
ArticleMDMA
Psychotherapy-supported MDMA treatment for PTSD.
ArticleLSD